Growth N. V. Biotech, 10% Owner at Black Diamond Therapeutics, Inc. (BDTX), bought 400,000 shares at $2.34 ($936K) on 2023-10-17, disclosed to the SEC on 2023-10-19.
Open-market purchase of $936k BDTX by 10% Owner. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade D.
Nothing distinguishes this filing.
| Filing → |
| BDTX | BUY | 2022-11-02 | $449K | — | Filing → |
| EPIX | BUY | 2022-10-28 | $8.2M | — | Filing → |
| EPIX | BUY | 2022-07-18 | $3.5M | — | Filing → |